cytokine profiles. These results provide hope, although they should be interpreted cautiously. The number of patients and the design of the study do not allow for a definitive conclusion on the role of statins in multiple sclerosis. The main concern with Vollmer and colleagues’ study is whether, without a placebo group, the reduction in disease activity as measured with MRI could be due to regr...
